Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (58)
2025 (697)
2024 (743)
2023 (750)
2022 (797)
2021 (829)
2020 (649)
2019 (542)
2018 (803)
2017 (914)
2016 (860)
2015 (649)
2014 (589)
2013 (461)
2012 (331)
2011 (191)
2010 (70)
2009 (38)
2008 (39)
2007 (13)
2006 (19)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (10057)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Vågesjö E
JSON
CSV
XLSX
TXT
Family name
Vågesjö
Given name
Evelina
Initials
E
ORCID
ORCID
0000-0002-4254-6875
Affiliations
Ilya Pharma AB, Uppsala, Sweden.
Division of Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
2 publications
PubMed
DOI
Crossref
Oral administration of CXCL12-expressing Limosilactobacillus reuteri improves colitis by local immunomodulatory actions in preclinical models.
Öhnstedt E
, Doñas C, Parv K, ...,
Vågesjö E
,
Phillipson M
Am J Physiol Gastrointest Liver Physiol
327
(2) G140-G153 [2024-08-01; online 2024-05-23]
PubMed
DOI
Crossref
Accelerated Wound Healing in Minipigs by On-Site Production and Delivery of CXCL12 by Transformed Lactic Acid Bacteria.
Öhnstedt E, Lofton Tomenius H, Frank P, ...,
Vågesjö E
, Phillipson M
Pharmaceutics
14
(2) - [2022-01-19; online 2022-01-19]
SciLifeLab Data Centre
Publications
9.5.1